First transgenic rat model developing progressive cortical neurofibrillary tangles

Neurobiology of Aging

Volumn 33, Issue 7, 2012, Pages 1448-1456

  Filipcik, Peter ^a,b   Zilka, Norbert ^a,b   Bugos, Ondrej ^a   Kucerak, Juraj ^a   Koson, Peter ^a   Novak, Petr ^a   Novak, Michal ^a,b  

^a INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^b Axon Neuroscience Forschungs und Entwicklungs GmbH   (Austria)

Author keywords

Alzheimer's disease; Neurofibrillary degeneration; Neuronal loss; Tauopathies; Transgenic models

Indexed keywords

TAU PROTEIN; THIOFLAVINE;

3 MICROTUBULE BINDING DOMAIN; AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARGYROPHILIA; ARTICLE; BRAIN CORTEX; BRAIN REGION; CELL LOSS; CONTROLLED STUDY; EMBRYO; HIPPOCAMPUS; HISTOPATHOLOGY; MOLECULAR RECOGNITION; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROLINE RICH REGION; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RAT;

ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEUROFIBRILLARY TANGLES; RATS; RATS, INBRED SHR; RATS, TRANSGENIC;

EID: 84861189566     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.10.015     Document Type: Article

References (34)

1. Binder L.I., Guillozet-Bongaarts A.L., Garcia-Sierra F., Berry R.W. Tau, tangles, and Alzheimer's disease. Biochim. Biophys. Acta 2005, 1739:216-223.
2. Csokova N., Skrabana R., Liebig H.D., Mederlyova A., Kontsek P., Novak M. Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases. Protein Expr. Purif 2004, 35:366-372.
3. Delacourte A. Tauopathies: recent insightes into old diseases. Folia Neuropathol 2005, 43:1-14.
4. Denk F., Wade-Martins R. Knockout and transgenic mouse models of tauopathies. Neurobiol. Aging 2009, 30:1-13.
5. Dorph-Petersen K.A., Nyengaard J.R., Gundersen H.J. Tissue shrinkage and unbiased stereological estimation of particle number and size. J. Microsc 2001, 204:232-246.
6. Eckermann K., Mocanu M.M., Khlistunova I., Biernat J., Nissen A., Hofmann A., Schonig K., Bujard H., Haemisch A., Mandelkow E., Zhou L., Rune G., Mandelkow E.M. The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy. J. Biol. Chem 2007, 282:31755-31765.
7. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad. Sci. Hung 1971, 19:1-8.
8. Gotz J., Deters N., Doldissen A., Bokhari L., Ke Y., Wiesner A., Schonrock N., Ittner L.M. A decade of tau transgenic animal models and beyond. Brain Pathol 2007, 17:91-103.
9. Greenberg S.G., Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:5827-5831.
10. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem 1986, 261:6084-6089.
11. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4913-4917.
12. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J.R., Pakkenberg B. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988, 96:857-881.
13. Hanes J., Zilka N., Bartkova M., Caletkova M., Dobrota D., Novak M. Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies. J. Neurochem 2009, 108:1167-1176.
14. Hrnkova M., Zilka N., Minichova Z., Koson P., Novak M. Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioral impairment in transgenic rats. Brain Res 2007, 1130:206-213.
15. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
16. Korenova M., Zilka N., Stozicka Z., Bugos O., Vanicky I., Novak M. NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy. J. Neurosci. Methods 2009, 177:108-114.
17. Korhonen P., van Groen T., Thornell A., Kyrylenko S., Soininen M.L., Ojala J., Peltomaa E., Tanila H., Salminen A., Mandelkow E.M., Soininen H. Neurobiol Aging 2010, 10.1016/j.neurobiolaging.2009.12.022.
18. Koson P., Zilka N., Kovac A., Kovacech B., Korenova M., Filipcik P., Novak M. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load. Eur. J. Neurosci 2008, 28:239-246.
19. Kovacech B., Skrabana R., Novak M. Transition of tau protein from disordered to misordered in Alzheimer's disease. Neurodegener. Dis 2010, 7:24-27.
20. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci 2001, 24:1121-1159.
21. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Gwinn-Hardy K., Paul Murphy M., Baker M., Yu X., Duff K., Hardy J., Corral A., Lin W.L., Yen S.H., Dickson D.W., Davies P., Hutton M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet 2000, 25:402-405.
22. Mocanu M.M., Nissen A., Eckermann K., Khlistunova I., Biernat J., Drexler D., Petrova O., Schonig K., Bujard H., Mandelkow E., Zhou L., Rune G., Mandelkow E.M. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci 2008, 28:737-748.
23. Novak M., Kabat J., Wischik C.M. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 1993, 12:365-370.
24. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, San Diego. 2nd Ed.
25. Ramsden M., Kotilinek L., Forster C., Paulson J., McGowan E., Santacruz K., Guimaraes A., Yue M., Lewis J., Carlson G., Hutton M., Ashe K.H. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci 2005, 25:10637-10647.
26. Sahara N., Lewis J., DeTure M., McGowan E., Dickson D.W., Hutton M., Yen S.H. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility. J. Neurochem 2002, 83:1498-1508.
27. Spillantini M.G., Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci 1998, 21:428-433.
28. Sun A., Nguyen X.V., Bing G. Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J. Histochem. Cytochem 2002, 50:463-472.
29. Tanemura K., Murayama M., Akagi T., Hashikawa T., Tominaga T., Ichikawa M., Yamaguchi H., Takashima A. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J. Neurosci 2002, 22:133-141.
30. Tatebayashi Y., Miyasaka T., Chui D.H., Akagi T., Mishima K., Iwasaki K., Fujiwara M., Tanemura K., Murayama M., Ishiguro K., Planel E., Sato S., Hashikawa T., Takashima A. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13896-13901.
31. Vechterova L., Kontsekova E., Zilka N., Ferencik M., Ravid R., Novak M. DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope. Neuroreport 2003, 14:87-91.
32. Wischik C.M., Novak M., Thogersen H.C., Edwards P.C., Runswick M.J., Jakes R., Walker J.E., Milstein C., Roth M., Klug A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:4506-4510.
33. Zilka N., Filipcik P., Koson P., Fialova L., Skrabana R., Zilkova M., Rolkova G., Kontsekova E., Novak M. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 2006, 580:3582-3588.
34. Zilka N., Korenova M., Novak M. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies. Acta Neuropathol 2009, 118:71-86.